[1] Gawrieh S, Chalasani N. Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Clin Liver Dis, 2018, 22:189-191. [2] Shimobayashi M, Albert V, Woelnerhanssen B, et al. Insulin resistance causes inflammation in adipose tissue. J CLIN INVEST, 2018, 128:14-16. [3] 孙婷婷,李京涛,魏海梁,等.TNFα/NF-κB信号通路调控非酒精性脂肪性肝病的研究现状.临床肝胆病杂志,2019,35:2095-2098. [4] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南.中华肝脏病杂志,2006,14:161-163. [5] Anstee QM, Mantovani A, Tilg H, et al. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat Rev Gastro Hepat, 2018, 15:66-69. [6] Hajifathalian K, Sagvand BT, Mccullough AJ . Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study. Hepatology, 2019, 70:66-68. [7] 秦海春,刘俊,杨慧,等.非酒精性脂肪性肝病患者血清中脂联素、内脏脂肪素水平及其相关性分析.现代消化及介入诊疗,2019,24:965-968. [8] 王玉浔,安雅臣,陈志全,等.血清瘦素、肿瘤坏死因子-α水平及胰岛素抵抗与非酒精性脂肪性肝病的关系.中华消化杂志,2012,32:188-190. [9] 张敏,陈璐,瞿美娣,等.2型糖尿病病人合并非酒精性脂肪性肝病的危险因素分析.肠外与肠内营养,2019,26:271-275. [10] 贾国瑜,韩涛,高磊,等.有氧运动和抗阻运动改善非酒精性脂肪肝的随机对照研究.中华肝脏病杂志,2018,26:34-41. [11] 陈洁,陈佳良,肖琨珉,等.炎症因子与非酒精性脂肪性肝病关系研究进展.医学综述,2019,25:2949-2954. [12] 杜科业,杨东亮,刘嘉.慢性乙型肝炎与调节性T细胞研究进展.实用肝脏病杂志,2019,22:613-616. [13] Jonadab E. Olguín, Itzel Medina-Andrade, Emmanuel Molina,et al. Early and Partial Reduction in CD4+ Foxp3+ Regulatory T Cells during Colitis-Associated Colon Cancer Induces CD4+ and CD8+ T Cell Activation Inhibiting Tumorigenesis.J Cancer, 2018, 9:239-249. [14] Klingberg O, Khattar R, Farrokhi K, et al. Inhibition of the FGL2:Fc γ RIIB/RIII Immunosuppressive Pathway Enhances Antiviral T cell and B Cell Responses Leading to Clearance of LCMV cl-13. Immunology, 2018, 154:64-67. [15] 田丽艳,范建高,蔡晓波,等.胰岛素抵抗与高脂饮食大鼠非酒精性脂肪性肝病的关系.肝脏,2007,12:28-30. |